Microburst Insulin Infusion (MII)
Scientific Studies (MII)
Journal Of Diabetes
July, 2017
“Recent research has demonstrated the burst insulin secretion of pancreatic beta cells in response to a carbohydrate load. A convincing body of evidence indicates that insulin is secreted in synchronized bursts from the pancreas to the hepatic portal vein…”
American Diabetes Association
September 2012
“Insulin pulses may account for as much as 70% of the total insulin secretion in the basal state. Adjacent beta cells in the islets adapt to each other via autocrine interaction, resulting in a coordinated secretion pattern. “
American Diabetes Association
“Insulin is secreted as discrete insulin secretory bursts at ∼5-min intervals into the hepatic portal vein, these pulses being attenuated early in the development of type 1 and type 2 diabetes mellitus (T2DM).”
Molecular Aspects of Medicine
“Type 2 diabetes (T2DM) results when increases in beta cell function and/or mass cannot compensate for rising insulin resistance. Numerous studies have documented the longitudinal changes in metabolism that occur…”
FACTS ABOUT THE MICROBURST INSULIN INFUSION TREATMENT (MII)
1. MII has been given to patients more than 200,000 times without any negative reactions, requiring no side effect warnings.
2. The device used for the Microburst Insulin Infusion Treatment has been cleared by the FDA without fails, recalls, claims or negative outcomes.
3. MII successfully stops and reverses the complications of both Type 1 and Type 2 diabetes.
4. After treatment, patients regain the proper levels of ATP, giving their cells energy and protection from the damage of diabetes-related complications.
Initial Consultation
Capture vital signs
Identify glucose level
Review medications
Assess overall condition
Review treatment
Set appointment to begin treatment
Treatment
1. Prep – capture vitals, identify glucose level, review records, assess current condition, establish IV, perform
2. 3 Sessions – pump administers 10 pulses over one 1 hour followed by
- Oral carbohydrates are given throughout sessions to maintain blood glucose levels and metabolic measurement.
- Glucose levels are taken approximately in 30-minute intervals or more frequently as medically indicated in patients with a tendency for hypoglycemia.
3.Upon completion, an evaluation takes place with patient discharge when stable.